Pharmacoeconomics in Perspective: A Primer on Research, Techniques, and InformationCRC Press, 2001 M01 12 From Pharmacoeconomics in Perspective: A Primer on Research, Techniques, and Information you will discover comprehensive explanations of principles in this sophisticated field through up-to-date research overviews, analysis types, research techniques, information evaluations. This unique book is primarily nonmathematical and highlights the qualitative details underpinning pharmacoeconomics for pharmacists and other medical professionals. This information is also a must for graduate students who need guidance through today's complicated pharmacy environment. Pharmacoeconomics in Perspective addresses a diverse yet increasingly growing slice of the healthcare environment where noneconomists are challenged to prepare, interpret, and use pharmacoeconomic information. This book provides you with the means to defend yourself against unscrupulous promotion of new drugs, unfounded conclusions in scientific literature, and research studies conducted with inaccurate methods.Pharmacoeconomics in Perspective provides charts, graphs, and figures to help you put all of its useful information into perspective. This invaluable book covers a broad range of topics within this subject area, including:
|
Contents
PHARMACOECONOMICS AS OUTCOMES RESEARCH | 3 |
UNIQUE POSITION OF HEALTH CARE | 4 |
DEVELOPMENT OF A CRITICAL PERSPECTIVE | 5 |
HEALTH CARE EXPENDITURES AND PHARMACOECONOMICS | 7 |
EMPHASIS ON PRESCRIPTION DRUGS | 8 |
TOOLS FOR EXPENDITURE DECISIONS | 9 |
PHARMACOECONOMICS WITHIN DRUG DEVELOPMENT | 11 |
REGULATIONS FOR PHARMACOECONOMIC DATA | 15 |
TECHNIQUES OF PHARMACOECONOMIC RESEARCH | 57 |
PERSPECTIVES FOR RESEARCH ANALYSES | 59 |
PERSPECTIVES FOR PHARMACOECONOMICS | 60 |
SCENARIOS OF PERSPECTIVE | 61 |
REPERCUSSIONS OF PERSPECTIVE | 62 |
DETERMINATION OF OUTCOME MEASURES | 65 |
DELINEATION OF OUTCOME MEASURES | 68 |
CATEGORIZATION OF PHARMACOECONOMICS COSTS | 71 |
INTEGRATION OF PHARMACOECONOMIC RESEARCH | 16 |
PHARMACOECONOMICS RESEARCH | 19 |
ANSWERS | 20 |
TYPES OF PHARMACOECONOMIC ANALYSES | 23 |
COSTOFILLNESS ANALYSIS | 25 |
COSTOFILLNESS EXAMPLES | 26 |
COSTBENEFIT ANALYSIS | 29 |
APPLICATIONS OF COSTBENEFIT ANALYSIS | 31 |
COSTBENEFIT EXAMPLES | 32 |
COSTEFFECTIVENESS ANALYSIS | 35 |
APPLICATIONS OF COSTEFFECTIVENESS ANALYSIS | 37 |
COSTEFFECTIVENESS EXAMPLES | 38 |
COSTUTILITY ANALYSIS | 41 |
COSTUTILITY EXAMPLES | 43 |
COSTMINIMIZATION ANALYSIS | 47 |
COSTMINIMIZATION EXAMPLES | 48 |
PHARMACOECONOMICS ANALYSES | 53 |
ANSWERS | 55 |
ISSUES IN CALCULATING COSTS | 73 |
SENSITIVITY ANALYSIS OF ASSUMPTIONS | 77 |
METHODS FOR TESTING SENSITIVITY | 79 |
PHARMACOECONOMICS TECHNIQUES | 81 |
ANSWERS | 82 |
EVALUATION OF PHARMACOECONOMIC INFORMATION | 85 |
REVIEW OF PHARMACOECONOMICS REARCH | 87 |
FACTORS IN RESEARCH EVALUATION | 89 |
REGULATORY AND ETHICAL CONSIDERATIONS | 91 |
ISSUES OF ETHICAL CONCERN | 92 |
SOURCES OF PHARMACOECONOMICS INFORMATION | 95 |
JOURNALS | 96 |
DATABASES | 97 |
PHARMACOECONOMICS INFORMATION | 99 |
ANSWERS | 100 |
103 | |
111 | |
Common terms and phrases
alternative analysis allows application appropriate assess assumptions basic benefits Bonk Bootman calculations cancer categories of costs cefoxitin celiac disease Chapter 11 Chapter 9 clinical comparison considered consumers cost categories cost-benefit analysis cost-effectiveness analysis cost-minimization analysis cost-of-illness analysis cost-utility analysis dipyridamole Direct medical costs disease drug development Drummond economic research edited effectiveness efficacy endomysial antibody evaluation focus ganciclovir groups guidelines health care decisions health care expenditures hospital hypertension illness indirect integration of pharmacoeconomic intervention issues journals macoeconomic mammography McGhan nomic nonmedical options outcome measures outcomes research parameters paroxetine patient payor phar Pharmaceutical Products Press pharmacoeco pharmacoeconomic analyses Pharmacoeconomic Costs pharmacoeconomic information pharmacoeconomic research pharmacoeconomic study pharmacoeconomic techniques Pharmacoeconomics in Perspective Phase physician potential prescription drugs Primer on Research provides QALY quality-adjusted quantified readers relevant sensitivity analysis society specific TECHNIQUES OF PHARMACOECONOMIC therapeutic therapies tion treatment types of pharmacoeconomic utility
Popular passages
Page 113 - Check here if billing address is different from POSTAGE & HANDLING shipping address and attach purchase order and (US: $5.00 for first book & $2.00 billing address information.
Page 113 - TOTAL (If paying in Canadian funds, Exp. Date convert using the current exchange rate, UNESCO Signature coupons welcome) Prices in US dollars and subject to change without notice. NAME INSTITUTION, ADDRESS CITY STATE/ZIP COUNTRY COUNTY (NY residents only)_ TEL FAX E-MAIL May we use your e-mail address for confirmations and other types of information?
Page 113 - Order From Your Local Bookstore or Directly From The Haworth Press, Inc. 10 Alice Street, Binghamton, New York 13904-1580 • USA TELEPHONE: 1 -800-HAWORTH...
Page 104 - M. (1995) Sensitivity analysis in economic evaluation: a review of published studies, Health Economics, 4: 355—71.
Page 103 - Evaluation of the endomysial antibody for celiac disease: operating properties and associated cost implications in clinical practice. Can J Gastroenterol 1997;1 1: 673-677.
Page 103 - Drummond, M., B. O'Brien, G. Stoddart, and G. Torrance. 1997. Methods for the Economic Evaluation of Health Care Programmes, 2d ed. Oxford: Oxford University Press. Epple, D., and R. Romano. 1996a. "Ends against the Middle: Determining Public Service Provision When There Are Private Alternatives.